Home > Insider Trading > Filing (0001104659-23-022868)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1933414	Mineralys Therapeutics Inc.	MLYS	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1315082	Ra Capital Healthcare Fund Lp	200 Berkeley Street 18Th Floor Boston MA 02116	Yes	No	No	No
1346824	Ra Capital Management, L.p.	200 Berkeley Street, 18Th Floor Boston MA 02116	Yes	No	No	No
1384859	Peter Kolchinsky	200 Berkeley Street 18Th Floor Boston MA 02116	Yes	No	No	No
1619841	M. Rajeev Shah	200 Berkeley Street 18Th Floor Boston MA 02116	Yes	No	No	No
1883840	Ra Capital Nexus Fund Iii, L.p.	200 Berkeley Street, 18Th Floor Boston MA 02116	Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-02-14	1,735,629	$0.00	1,735,629	No	4	C	Indirect	See footnotes
Common Stock	Acquisiton	2023-02-14	131,600	$16.00	1,867,229	No	4	P	Indirect	See footnotes
Common Stock	Acquisiton	2023-02-14	192,847	$0.00	192,847	No	4	C	Indirect	See footnotes
Common Stock	Acquisiton	2023-02-14	1,118,400	$16.00	1,311,247	No	4	P	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnotes
No	4	P	Indirect	See footnotes
No	4	C	Indirect	See footnotes
No	4	P	Indirect	See footnotes

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2023-02-14	1,735,629	$0.00	1,735,629	$0.00
Common Stock	Series B Preferred Stock	Disposition	2023-02-14	192,847	$0.00	192,847	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

Each share of preferred stock of the Issuer automatically converted into shares of common stock on a 10.798-for-one basis (which reflects the reverse stock split effected by the Issuer on February 1, 2023) upon closing of the Issuer's initial public offering.
Shares are held directly by RA Capital Nexus Fund III, L.P. (the "Nexus Fund III").
RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and Nexus Fund III. The general partner of RA Capital Management, L.P. is RA Capital Management GP, LLC (the "Adviser GP"), of which Peter Kolchinsky, Ph.D. and Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah may be deemed to have voting and investment power over the shares held of record by the Fund and Nexus Fund III. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
Shares are held directly by the Fund.